Zynex Emerges from Chapter 11; All Existing Equity Cancelled, New Control Established

summarizeSummary

Zynex has officially emerged from Chapter 11 bankruptcy, resulting in the cancellation of all existing equity and a complete change of control to the Plan Sponsor.

check_boxKey Events

• Emergence from Chapter 11 Bankruptcy

  On March 26, 2026, Zynex officially emerged from Chapter 11 protection after satisfying the conditions of its reorganization plan.

• All Existing Equity Interests Cancelled

  All previously issued and outstanding shares of common stock and equity awards were cancelled, released, and extinguished, becoming of no further force or effect.

• New Ownership and Board Appointed

  Altivera Medical Holdings LLC, the Plan Sponsor, received 100% of the new common stock, establishing a complete change of control. New directors were appointed to the Company's board.

• Secured $10 Million Exit Financing

  The company entered into an Exit Credit Agreement for a $10.0 million senior secured term loan, maturing in April 2034, with obligations convertible into common stock.

auto_awesomeAnalysis

This filing marks the definitive emergence of Zynex from Chapter 11 bankruptcy, a critical development following the plan's confirmation on March 19, 2026. The most significant impact for prior shareholders is the complete cancellation and extinguishment of all outstanding equity interests, rendering old shares worthless. A new capital structure is in place, with Altivera Medical Holdings LLC, the Plan Sponsor, receiving 100% of the newly issued common stock, signifying a full change of control. The company also secured $10.0 million in new senior secured term loans, providing exit financing but convertible into common stock. This event fundamentally alters the investment thesis for anyone holding pre-bankruptcy shares.